Last reviewed · How we verify
NCT06369168: OhrHit
Auricular Acupuncture and Hot Flashes During Adjuvant Endocrine Therapy
NA trial testing auricular acupuncture in Hot Flashes in 107 participants. Completed in 8 September 2025.
8 September 2025
Quick facts
| Lead sponsor | Kliniken Essen-Mitte |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 107 |
| Start date | 17 June 2024 |
| Primary completion | 8 September 2025 |
| Estimated completion | 8 September 2025 |
| Sites | 2 locations across Germany |
Drugs / interventions tested
- auricular acupuncture
Conditions studied
- Hot Flashes — all drugs for Hot Flashes →
Sponsor
Kliniken Essen-Mitte — full company profile →
Who can join
Adults 18 to 75, female only, with Hot Flashes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With this clinical trial we investigate whether auricular acupuncture during adjuvant endocrine therapy has an improving effect on hot flashes, which are often perceived as psychologically and physically stressful in self-assessment of women with breast cancer. Empirical studies indicate that body acupuncture has positive effects on hot flashes. As auricular acupuncture offers a number of advantages over body acupuncture, a three-armed randomised controlled research design is being used to investigate whether hot flashes caused by endocrine therapy are also reduced by ear acupuncture. Balanced ear acupuncture will be compared with NADA ear acupuncture in terms of efficacy and effectiveness. In addition, the effects of the two forms of therapy on the patients' individual quality of life, fatigue, stress perception and sleep quality will be analysed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06369168
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hot Flashes
Currently open trials in the same condition.
- NCT06957691 — Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Pro · Phase 2 · recruiting
- NCT07335224 — Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture · NA · recruiting
- NCT07455812 — A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Men · active not recruiting
- NCT06716554 — Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, P · NA · recruiting
- NCT06440967 — A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy · Phase 3 · active not recruiting
Other Kliniken Essen-Mitte trials
Trials by the same sponsor.
- NCT07311083 — Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy · NA · not yet recruiting
- NCT06421181 — Hemodynamic Effects of Anesthesia Induction · recruiting
- NCT06764914 — Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache · not yet recruiting
- NCT06355362 — Association of Intraoperative Hemodynamic Characteristics to Postoperative Complications and Mortality · not yet recruiting
- NCT05928702 — Temperature-elevating Armbaths for Arterial Hypertension · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06369168 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kliniken Essen-Mitte
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06369168.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing